DIPB vs SIFIB for pain control after total hip replacement
Comparison of the Effects of Deep Iliacus Plane Block (DIPB) and Suprainguinal Fascia Iliaca Block (SIFIB) on Postoperative Analgesia in Patients Undergoing Hip Surgery: A Randomized Controlled Study
This will test whether the Deep Iliacus Plane Block (DIPB) or the Suprainguinal Fascia Iliaca Block (SIFIB) gives better pain relief and less leg weakness for adults having elective total hip replacement.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sivas Numune Hospital Government |
| Locations | 2 sites (Sivas, Sivas and 1 other locations) |
| Trial ID | NCT07452120 on ClinicalTrials.gov |
What this trial studies
In this randomized, double-blind trial, 70 adults undergoing elective primary total hip arthroplasty under spinal anesthesia will be assigned to receive either a DIPB or a SIFIB at the end of surgery. Investigators will record postoperative pain scores, opioid consumption, motor block, and block-related complications over 48 hours. The primary aim is to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared with SIFIB. Findings will help guide choice of regional analgesia to support earlier mobilization and safer recovery after hip replacement.
Who should consider this trial
Good fit: Adults (age ≥18) with ASA physical status I–III scheduled for elective primary total hip arthroplasty under spinal anesthesia who can provide informed consent are ideal candidates.
Not a fit: Patients with contraindications to regional anesthesia (such as coagulopathy, local infection), significant pre-existing lower limb neurological deficits, or inability to consent would not be eligible and are unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, the results could provide better pain control with less motor weakness, helping patients mobilize sooner after hip replacement.
How similar studies have performed: SIFIB is widely used and effective for cutaneous analgesia after hip surgery, while DIPB is a newer technique with anatomical and preliminary clinical reports suggesting improved deep joint analgesia but limited randomized evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged ≥18 years * ASA physical status I-III * Scheduled for elective primary total hip arthroplasty under spinal anesthesia * Ability to understand the study procedures and provide informed consent Exclusion Criteria: * Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia * Infection at the block application site * Hemodynamic instability * Known allergy to local anesthetics * Pre-existing significant neurological or motor deficits in the lower extremities * Cognitive impairment preventing pain assessment * Refusal to participate or inability to provide informed consent
Where this trial is running
Sivas, Sivas and 1 other locations
- Sivas Numune Hospital — Sivas, Sivas, Turkey (Türkiye) (Not_yet_recruiting)
- Sivas Numune Hospital — Sivas, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Fatih BALCI — Sivas Numune Hospital, Department of Anesthesiology and Reanimation
- Study coordinator: Fatih Balcı, MD
- Email: fatihbalci05@gmail.com
- Phone: +90 545 864 76 57
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.